Skip to main content
. 2018 Apr 24;8(2):208–216. doi: 10.1002/cpdd.462

Figure 2.

Figure 2

Upadacitinib mean ± SD plasma concentration‐versus‐time profiles following administration of single oral doses of upadacitinib IR and ER formulations to healthy subjects. The first 24 hours are shown on a larger scale in the inset. IR, immediate‐release; ER, extended‐release.